Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
(By Emmarie Huetteman and Rachel Bluth for Kaiser Health News) Senators railed against pharmaceutical executives Tuesday for declining to testify
Read More
Part D/Prescription Drugs
AstraZeneca strikes pay-for-performance deal with UPMC Health Plan
(By Alia Paavola for Becker’s Hospital Review) AstraZeneca has agreed to a pay-for-performance deal with UPMC Health Plan, according to STAT.
Read MoreAlex Azar: Why drug prices keep going up — and why they need to come down
(By Alex M. Azar II for STAT) Two years ago this month, President Trump promised the American people that he would stop
Read MoreSteep Climb In Benzodiazepine Prescribing By Primary Care Doctors
(By Rhitu Chatterjee for NPR) The percentage of outpatient medical visits that led to a benzodiazepine prescription doubled from 2003 to 2015,
Read MoreHospital-owned drug company to offer 20 generics in 2019
(By Alia Paavola for Becker’s Hospital Review) Civica Rx, the nonprofit generic drug company formed by a group of hospital
Read MoreDrug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
(By Shefali Luthra for Kaiser Health News) The next presidential primary contests are more than a year away. But presumed
Read MoreConsumers less likely to take a drug when its price is included in ads, study finds
(By Alia Paavola for Becker’s Hospital Review) When prices were included in television advertisements for higher-cost drugs, consumers were less
Read MoreCalifornia Doctors Alarmed As State Links Their Opioid Prescriptions to Deaths
(By April Dembosky for NPR) About a year ago, Dr. Ako Jacintho of San Francisco returned home from traveling to
Read MoreWalgreens pays $269M to settle billing fraud lawsuits
(By Ayla Ellison for Becker’s Hospital Review) Walgreens Boots Alliance has agreed to pay $269.2 million to settle two healthcare
Read MorePhRMA spent a record-breaking $27.5 million on lobbying in 2018, new filings show
(By Nicholas Florko for STAT) WASHINGTON — PhRMA, the eminent lobbying group for the pharmaceutical industry, spent more than $27.5
Read More